ImClone Investigational Site

Washington, North Carolina 27889

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients — Completed